Short and Medium Term Results of Nitinol Self-Expending Stent (LifeStent) Implantation for Iliac Arteriosclerosis Obliteran_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 CHENBin , GAOPeng , YUJi-xiang , LIYu , MENGRan-ran , HUIFui-fui ,  YANGBin

Department of Vascular Surgery, The First People's Hospital of Jining City, Jining 272000, Shandong Province, China;

Corresponding?author：

YANGBin, Email: 845243222@qq.com

Keywords：

Artery occlusive disease; Iliac artery; Self-expending stent; Angioplasty

DOI：

10.7507/1007-9424.20160157

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To evaluate short and medium term results of nitinol self-expending stent (LifeStent) implantation for iliac arteriosclerosis obliteran. Methods The clinical data of 75 limbs iliac artery occlusions in 64 patients from June 2011 to June 2014 in this hospital were analyzed retrospectively. The postoperative ankle brachial index (ABI), limb salvage rate, primary and secondary patency rate, and postoperative complications were evaluated. Results There were 75 limbs iliac artery occlusions in 64 patients (54 males and 10 females), 11 lesions were type A of TASCⅡ, 26 lesions were type B of TASCⅡ, 29 lesions were type C of TASCⅡ, 9 lesions were type D of TASCⅡ. The postoperative ABI was significantly higher than that preoperative ABI (0.94±0.16 versus 0.29±0.20, t=-24.7, P < 0.01). The following-up time was (22±10) months, 5 patients were lost to follow-up. In 12 and 24 months after surgery, the cumulative primary patency rates were 79% and 60%, respectively, the cumulative second patency rates were 91% and 84%, respectively, the limb salvage rates were 96% and 94%, respectively. Complications occurred in 5 patients (7.8%). There was no severe complications and inhospital mortality. Conclusion Clinical efficacy of short and medium term is satisfactory by nitinol self-expending stents implantation (LifeStent) for iliac arteriosclerosis obliteran, but long term efficacy remains to be further studied.

Citation： CHENBin, GAOPeng, YUJi-xiang, LIYu, MENGRan-ran, HUIFui-fui, YANGBin. Short and Medium Term Results of Nitinol Self-Expending Stent (LifeStent) Implantation for Iliac Arteriosclerosis Obliteran. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2016, 23(5): 586-589. doi: 10.7507/1007-9424.20160157 Copy

1.	Balzer JO, khan V, Thalhammer A, et al. Below the knee PTA in critical limb ischemia results after 12 months: single center experience. Eur J Radiol, 2010, 75(1): 31-42.
2.	Norgren L, Hiatt WR, Dormandy JA, et al. TASCⅡWorking Group. Inter-society consensus for the management of peripheral arterial disease. Int Angiol, 2007, 26(2): 81-157.
3.	Baril DT, Chaer RA, Rhee RY, et al. Endovascular interventions for TASCⅡD femoropopliteal lesions. J Vasc Surg, 2010, 51(6): 1406-1412.
4.	邢彤, 楊寶鐘, 宋盛晗, 等.腔內支架植入治療TASCⅡC、D型股腘動脈慢性閉塞病變.中華普通外科雜志, 2012, 27(8): 616-618.
5.	kim SJ, kim W, kim JB, et al. Determinants of procedural success and patency following subintimal angioplasty in patients with TASC C and D femoropopliteal arterial disease. Cire J, 2010, 74(9): 1959-1964.
6.	葉煒, 劉昌偉, 李擁軍, 等.老年人下肢動脈硬化閉塞癥腔內治療效果分析.中華外科雜志, 2010, 48(4): 261-264.
7.	朱雅亭, 郭偉.周圍動脈支架內再狹窄的處理.中華醫學雜志, 2012, 92(19), 1363-1364.
8.	溫志國, 杜麗蘋, 李小華, 等. TASC C D型下肢動脈硬化閉塞癥的腔內治療.中華普通外科雜志, 2014, 29(1): 29-31.
9.	吳慶華, 楊培.論TASC分型與下肢動脈硬化閉塞的治療選擇.中華普通外科雜志, 2009, 24(6): 433-435.
10.	The task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC). ESC guidelines on the diagnosis and treatment of peripheral artery diseases. http://www.escardio.org/guidelines-surveys/esc-guidelines/about/Pages/rules-writing.aspx.
11.	黃斌, 陳熹陽, 趙紀春, 等.外科結合腔內治療下肢動脈硬化閉塞癥.中國普外基礎與臨床, 2015, 22(8): 926-928.
12.	陳忠, 王盛, 唐小斌, 等.主髂動脈硬化閉塞癥的腔內治療.心肺血管病雜志, 2010, 29(6): 446-448.
13.	黃俊杰, 張秀軍, 張晶.導管直接溶栓聯合動脈成形術治療慢性股淺動脈閉塞癥.中華普外科雜志, 2014, 29(9): 704-707.
14.	吳田方, 代遠斌.不同材料周圍動脈支架置入治療動脈硬化閉塞癥的研究與進展.中國組織工程研究, 2012, 16(12): 2261-2264.
15.	Iida O, Nanto S, Uematsu M, et al. Influence of stent fracture on the long-term patency in the femoro-popliteal artery: experience of 4years. JACC Cardiovasc Interv, 2009, 2(7): 665-671.
16.	George JC, Rosen ES, Nachtigall J, et al. SUPERA interwoven nitinolStent Outcomes in Above-knee IntErventions (SAkE) study. J Vasc Interv Radiol, 2014, 25(6): 954-961.
17.	Lejay A, Thaveau F, Girsowicz E, et al. Stent evolution for peripheral arterial disease. J Cardiovasc Surg (Torino), 2012, 53(1 Suppl 1): 171-179.
18.	楊心蕊, 陸信武, 葉開創, 等.自膨式裸支架治療股腘動脈狹窄閉塞性病變的臨床評價.中華普通外科雜志, 2014, 29(8): 600-602.
19.	Adlakha S, Sheikh M, Wu J, et al. Stent fracture in the coronary and peripheral arteries. J Interv Cardiol, 2010, 23(4): 411-419.
20.	Farzan G, Niju BN, Anatoliy T, et al. Use of Viabahn stent for the treatment of in-stent restenosis in the superficial femoral artery.Cardiovasc Revasc Med, 2012, 13: e3-e19.
21.	田碩, 黃新天, 殷敏毅, 等.下肢動脈粥樣硬化閉塞癥腔內治療后再閉塞的原因分析及應對策略.中國血管外科雜志:電子版, 2013, 5(2): 83-85.
22.	Bernstein O, Chalmers N. New treatments for infrapopliteal disease:devices, techniques, and outcomes so far. Cardiovasc Intervent Radiol, 2012, 35(4): 715-724.
23.	陳彬, 劉軍軍, 趙宗剛, 等.不同自膨式金屬支架混合置入治療股腘動脈硬化閉塞:生物相容性及保肢率.中國組織工程研究, 2015, 19(8): 1233-1238.

1. Balzer JO, khan V, Thalhammer A, et al. Below the knee PTA in critical limb ischemia results after 12 months: single center experience. Eur J Radiol, 2010, 75(1): 31-42.
2. Norgren L, Hiatt WR, Dormandy JA, et al. TASCⅡWorking Group. Inter-society consensus for the management of peripheral arterial disease. Int Angiol, 2007, 26(2): 81-157.
3. Baril DT, Chaer RA, Rhee RY, et al. Endovascular interventions for TASCⅡD femoropopliteal lesions. J Vasc Surg, 2010, 51(6): 1406-1412.
4. 邢彤, 楊寶鐘, 宋盛晗, 等.腔內支架植入治療TASCⅡC、D型股腘動脈慢性閉塞病變.中華普通外科雜志, 2012, 27(8): 616-618.
5. kim SJ, kim W, kim JB, et al. Determinants of procedural success and patency following subintimal angioplasty in patients with TASC C and D femoropopliteal arterial disease. Cire J, 2010, 74(9): 1959-1964.
6. 葉煒, 劉昌偉, 李擁軍, 等.老年人下肢動脈硬化閉塞癥腔內治療效果分析.中華外科雜志, 2010, 48(4): 261-264.
7. 朱雅亭, 郭偉.周圍動脈支架內再狹窄的處理.中華醫學雜志, 2012, 92(19), 1363-1364.
8. 溫志國, 杜麗蘋, 李小華, 等. TASC C D型下肢動脈硬化閉塞癥的腔內治療.中華普通外科雜志, 2014, 29(1): 29-31.
9. 吳慶華, 楊培.論TASC分型與下肢動脈硬化閉塞的治療選擇.中華普通外科雜志, 2009, 24(6): 433-435.
10. The task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC). ESC guidelines on the diagnosis and treatment of peripheral artery diseases. http://www.escardio.org/guidelines-surveys/esc-guidelines/about/Pages/rules-writing.aspx.
11. 黃斌, 陳熹陽, 趙紀春, 等.外科結合腔內治療下肢動脈硬化閉塞癥.中國普外基礎與臨床, 2015, 22(8): 926-928.
12. 陳忠, 王盛, 唐小斌, 等.主髂動脈硬化閉塞癥的腔內治療.心肺血管病雜志, 2010, 29(6): 446-448.
13. 黃俊杰, 張秀軍, 張晶.導管直接溶栓聯合動脈成形術治療慢性股淺動脈閉塞癥.中華普外科雜志, 2014, 29(9): 704-707.
14. 吳田方, 代遠斌.不同材料周圍動脈支架置入治療動脈硬化閉塞癥的研究與進展.中國組織工程研究, 2012, 16(12): 2261-2264.
15. Iida O, Nanto S, Uematsu M, et al. Influence of stent fracture on the long-term patency in the femoro-popliteal artery: experience of 4years. JACC Cardiovasc Interv, 2009, 2(7): 665-671.
16. George JC, Rosen ES, Nachtigall J, et al. SUPERA interwoven nitinolStent Outcomes in Above-knee IntErventions (SAkE) study. J Vasc Interv Radiol, 2014, 25(6): 954-961.
17. Lejay A, Thaveau F, Girsowicz E, et al. Stent evolution for peripheral arterial disease. J Cardiovasc Surg (Torino), 2012, 53(1 Suppl 1): 171-179.
18. 楊心蕊, 陸信武, 葉開創, 等.自膨式裸支架治療股腘動脈狹窄閉塞性病變的臨床評價.中華普通外科雜志, 2014, 29(8): 600-602.
19. Adlakha S, Sheikh M, Wu J, et al. Stent fracture in the coronary and peripheral arteries. J Interv Cardiol, 2010, 23(4): 411-419.
20. Farzan G, Niju BN, Anatoliy T, et al. Use of Viabahn stent for the treatment of in-stent restenosis in the superficial femoral artery.Cardiovasc Revasc Med, 2012, 13: e3-e19.
21. 田碩, 黃新天, 殷敏毅, 等.下肢動脈粥樣硬化閉塞癥腔內治療后再閉塞的原因分析及應對策略.中國血管外科雜志:電子版, 2013, 5(2): 83-85.
22. Bernstein O, Chalmers N. New treatments for infrapopliteal disease:devices, techniques, and outcomes so far. Cardiovasc Intervent Radiol, 2012, 35(4): 715-724.
23. 陳彬, 劉軍軍, 趙宗剛, 等.不同自膨式金屬支架混合置入治療股腘動脈硬化閉塞:生物相容性及保肢率.中國組織工程研究, 2015, 19(8): 1233-1238.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Short and Medium Term Results of Nitinol Self-Expending Stent (LifeStent) Implantation for Iliac Arteriosclerosis Obliteran

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content